Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms-Reference-Cited by-同舟云学术

Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms

Published:2016-11-01 Issue:11 Volume:2 Page:1452
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Schwaederle Maria¹,Zhao Melissa¹,Lee J. Jack²,Lazar Vladimir³,Leyland-Jones Brian⁴,Schilsky Richard L.⁵,Mendelsohn John⁶,Kurzrock Razelle⁷

Affiliation:

1. Center for Personalized Cancer Therapy, Division of Hematology and Oncology, University of California, San Diego

2. Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston

3. Worldwide Innovative Network for Personalized Cancer Therapy, Villejuif, France

4. Avera Cancer Institute, Sioux Falls, South Dakota

5. Worldwide Innovative Network for Personalized Cancer Therapy, Villejuif, France5American Society of Clinical Oncology, Alexandria, Virginia

6. Worldwide Innovative Network for Personalized Cancer Therapy, Villejuif, France6Khalifa Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston

7. Center for Personalized Cancer Therapy, Division of Hematology and Oncology, University of California, San Diego3Worldwide Innovative Network for Personalized Cancer Therapy, Villejuif, France

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit;Frontiers in Oncology;2024-05-15

2. From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views;The Oncologist;2024-05-07

3. Comparison of Prognostic Scores in Early Phase Clinical Trials: A 10-year Single Centre Australian Experience;Anticancer Research;2024-04-27

4. Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types;The Journal of Molecular Diagnostics;2024-04

5. Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design;Cancer Treatment Reviews;2024-04